Daiichi Sankyo (Germany)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
1.3K
Total Open
Publications
748
Total
Citations
34K
Open Access
Percentage
57%
Total
Publications
1.3K
Total Open
Publications
748
Total
Citations
34K
Breakdown
Publisher Open
35%
Both
17%
Other Platform Open
5%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 15%
100
Hybrid 35%
237
No Guarantees 50%
344
Other Platform Open
Domain 81%
236
Institution 23%
67
Preprint 8%
23
Public 6%
18
Other Internet 5%
16
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 234 |
Europe PMC | Domain | 101 |
University of Birmingham - University of Birmingham Research Portal | Institution | 25 |
Research Square | Preprint | 20 |
Semantic Scholar | Public | 16 |
DOI | Other Internet | 14 |
University of Zurich - Zurich Open Repository and Archive | Institution | 6 |
California Digital Library - eScholarship | Other Internet | 6 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 5 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 4 |